RNTX logo

Rein Therapeutics Inc.

RNTX
Healthcare|Biotechnology|US
$0.61
+0.00 (+0.28%)
Cash / Share
$1.34
Next Earnings Report
Mar 3, 2027
EPS est. -$0.13
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest May 4, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (2)

Sep 2027
Est. completion
P2Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
NCT06968845n=120
May 2032
Est. completion
P3Metastatic Kidney Cancer
CARE1 Pragmatic Clinical Trial
NCT06364631n=1,250

Recent Press Releases

Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Nov 2, 2026 · GlobeNewsWire
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
Sep 4, 2026 · GlobeNewsWire
Rein Therapeutics to Present at Upcoming September Investor Conferences
Sep 3, 2026 · GlobeNewsWire
Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis
Aug 20, 2026 · GlobeNewsWire
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026 · GlobeNewsWire

SEC Filings (61)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 4, 20268-KMaterial eventDocumentIndex
Aug 27, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 21, 20268-KMaterial eventDocumentIndex
Jul 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 8, 2026ARSAnnual report to holdersDocumentIndex
Jun 8, 2026DEFA14AProxy / shareholder voteDocumentIndex
Jun 8, 2026DEF 14AProxy / shareholder voteDocumentIndex
May 28, 2026PRE 14AProxy / shareholder voteDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
May 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 4, 20268-KMaterial eventDocumentIndex
May 4, 2026424B5Offering prospectusDocumentIndex
Apr 28, 2026S-1IPO / offering registrationDocumentIndex
Apr 27, 202610-K/AAnnual reportDocumentIndex
Mar 26, 202610-KAnnual reportDocumentIndex
Mar 2, 20268-KMaterial eventDocumentIndex
Feb 19, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 16, 20268-KMaterial eventDocumentIndex
Dec 11, 20258-KMaterial eventDocumentIndex
Nov 14, 202510-QQuarterly reportDocumentIndex
Nov 3, 20258-KMaterial eventDocumentIndex
Oct 24, 20258-KMaterial eventDocumentIndex
Oct 9, 20258-KMaterial eventDocumentIndex
Sep 26, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Sep 22, 20258-KMaterial eventDocumentIndex
Sep 9, 20258-KMaterial eventDocumentIndex
Sep 5, 2025EFFECTDocumentIndex
Sep 3, 2025S-1IPO / offering registrationDocumentIndex
Aug 19, 20258-KMaterial eventDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Jul 30, 20258-KMaterial eventDocumentIndex
Jul 30, 2025424B5Offering prospectusDocumentIndex